Global logistics provider GEODIS has recently announced the opening of a new state-of-the-art cold chain facility in Paris, France. This facility is designed to meet the growing demand for temperature-controlled logistics, particularly in the pharmaceutical and life sciences sectors. The new facility, equipped with advanced temperature monitoring and control systems, will enhance GEODIS’s ability to handle sensitive medical supplies, including vaccines and biologics, ensuring that they are stored and transported under optimal conditions.
The cold chain facility is part of GEODIS’s broader strategy to expand its capabilities in the healthcare sector, a market that has seen significant growth due to the ongoing global health challenges. With this new facility, GEODIS aims to strengthen its position as a leading provider of specialized logistics services, offering comprehensive solutions that meet the stringent regulatory requirements of the pharmaceutical industry.
